“ TROMBOEMBOLISMO PULMONAR AGUDO, SU INCIDENCIA Y PRINCIPALES FACTORES DE RIESGO ADQUIRIDOS ASOCIADOS, DE FEBRERO DEL 2006 A FEBRERO DEL 2012 EN EL HOSPITAL GENERAL DE ATIZAPÁN” [PDF]
, 2014 Mosqueda Martínez, Gerardo +1 more
core
Estados Trombofílicos no doente com cancro. Incidência, profilaxia, tratamento e perpetivas futuras [PDF]
, 2012 Sara Raquel Lemos Rocha
core
New anticoagulants for the treatment of venous thromboembolism. [PDF]
J Bras Pneumol, 2016 Fernandes CJ +5 more
europepmc +1 more source
Deep vein thrombosis of lower limbs in patients with COVID-19. [PDF]
J Vasc Bras, 2023 Saliba OA +4 more
europepmc +1 more source
Tromboembolismo e câncer de mama: quando indicar a profilaxia medicamentosa? [PDF]
, 2008 ALDRIGHI, José Mendes +2 more
core +2 more sources
Successful use of rivaroxaban achieving therapeutic anti-factor xa levels in a morbidly obese patient with acute intermediate-high risk pulmonary embolism. [PDF]
J Vasc Bras, 2023 Dah K +3 more
europepmc +1 more source
Reacciones adversas medicamentosas de Bemiparina y Heparina sódica en pacientes de 35 a 85 años de edad ingresados en la unidad de cuidados intensivos del Hospital Alemán Nicaragüense; Managua, Agosto 2010 a Marzo 2011 [PDF]
, 2011 Cerda Rivera, Jalyma Ernestina +2 more
core
Validation of surgical care quality indicators in the Brazilian Unified Health System. [PDF]
Rev Saude Publica, 2023 Caldas ACSG +5 more
europepmc +1 more source
Prevalence of venous thromboembolism and associated factors in COVID-19 patients at a provincial public hospital in southern Brazil. [PDF]
J Vasc BrasDutra BV +7 more
europepmc +1 more source
Venous thromboembolism prophylaxis after total knee arthroplasty (TKA): aspirin vs. rivaroxaban. [PDF]
Rev Bras Ortop, 2018 Colleoni JL +5 more
europepmc +1 more source